Lectures by Invitation

Lectures by Invitation


9/30/2016 2nd International Conference on Immune Responses to Biosurfaces: Mechanisms and Therapeutic Interventions, Ixia, Rhodes, Greece. Compstatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention.

6/29/2016 9th International Conference on Complement Therapeutics, Ixia, Rhodes, Greece. Compstatin Cp40 (AMY-101): A C3 tergeted complement inhibitor reaching its prime for bedtside intervention.

6/25/2016 13th International Conference on Innate Immunity, Ixia, Rhodes, Greece. Compastatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention.

11/18/2015 IPITA, IXA, CTS Joint Congress, Melbourne, Australia. New reagents to regulate complement activation.

9/2/2015 8th International Conference on Complement Therapeutics, Chania, Crete, Greece. An update on the preclinical and clinical development of the therapeutic C3 inhibitor Cp40.

8/11/2015 12th World Congress on Inflammation, Boston, MA, USA . Compstatin CP40: an Immune Modulator on a Journey from Disease Models to Clinical Development.

8/9/2015 12th World Congress on Inflammation, Boston, MA, USA. Complement: More Than a "Guard" against Pathogens.

6/21/2015 12th International Conference on Innate Immunity, Chania, Crete, Greece. Compstatin Cp40: an immune modulator on a journey from disease models to clinical development.

5/3/2015 State of the Art Speaker, American Transplantation Conference, Philadelphia, PA, USA.  Complement: More Than a "Guard" Against Pathogens.

1/9/2015 University of Florence, Italy. Complement: morer than a "guard" against pathogens.

9/29/2014 1st International Conference on Immune Responses to Biosurfaces: Mechanisms and Therapeutic Interventions, Chania, Crete, Greece. Cp40: a complement inhibitor getting ready for primetime.

6/5/2014 11th International Conference on Innate Immunity, Olympia, Greece. Complement C3 ihibitors getting ready for primetime: compstatin Cp40 in local and systemic applications.

5/22/2014 Linneaus University Center for Biomaterials Chemistry, Kalmar, Sweden. Therapeutic complement inhibitionat the level of C3: microconceptions, myths, and novel insight.

4/9/2014 Institute for Systemic Inflammation Research, Luebeck University, Luebeck, Germany. Innate Immunity: more than a guard against invading pathogens.

3/27/2014 Aplastic Anemia & MDS International Foundation. Bone Marrow Failure Disease Scientific Symposium, Rockville, MD. Rational and preclinical development of novel strategy of complement inhibition.

8/25/2013 15th International Congress of Immunology, Milan, Italy.  The Renaissance of Complement.

6/27/2013 10th International Conference on Innate Immunity, Kos, Greece. Preclinical development of compstatin: progress, applications, and insight about therapeutic complement inhibition at the level of C3.

6/19/2013 6th International Conference on Complement Therapeutics, Kos, Greece. Therapeutic complement inhibition at the level of C3: microconceptions, myths, and novel insight.

1/24/2013 Rudbeck Seminar, Uppsala University, Sweden. Innate Immunity: more than a guard against invading pathogens.

1/18/2013 15th Rheumatoly Scientific Meeting of the Northwestern Greece, Ioannina, Greece. Innate Immunity: more than a "guard" against pathogens.

1/17/2013 Medical and Dental Societies, Agrinion, Greece. Microbes: Friends or Foes?.

1/16/2013 EKFE, Arta, Greece. Microbes: Friends or Foes?.

1/12/2013 Balances: basic knowledge and development in hematology, Ioannina, Greece. Innate Immunity: therapeutic approaches with empasis on hematological diseases.

10/13/2012 XXIV International Complement Workshop, Chania, Crete, Greece. Bringing Compstatin to the next level: novel analogs with improved potency, pharmacokinetic profiles and administration options suitable for systemic application.

10/8/2012 Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging and Therapeutic Targets, Chania, Crete, Greece. Shifting a parigm? Unexpected functions of complement in cancer.

6/26/2012 9th International Conference on Innate Immunity, Rhodes, Greece. Compstatin: A Complement inhibitor on its way to clinical application.

6/8/2012 13th Naples Workshop on Bioactive Peptides, Naples, Italy. Peptide based complement inhibitors: from bench to bedside.

2/21/2012 Sanquin Blood Supply Foundation, Dept. of Immunopathology, Amsterdanm, The Netherlands. Innate Immunity: more than a "guard" against invading pathogens.

11/8/2011 State of the Art lecture, ACR/ARHP Annual Scientific Meetnig, Chicago. Complementary Roles for Complement in Rheumatic Diseases.

10/26/2011 Dept. di Biochimica e Biotecnologie Mediche, Dept. Assistenziale di Clinica Medica, Universita di Napoli Federico II. Innate Immunity: more than a "guard" against invading pathogens.

10/25/2011 Instituto di Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche, Naples, Italy. Structure and function of complement proteins and design of complement inhibitors.

10/21/2011 Deaprtment of Medicine, Division of Allergy and Immunology, University of Pennsylvania. Innate Immunity: more than a "guard" against invading pathogens.

10/6/2011 Department of Ophthalmology, University of Pennsylvania. Innate Immunity: more than a "guard" against invading pathogens.

10/5/2011 Center for Research on Reproduction and Women's Health, University of Pennsylvania Perelman School of Medicine. Innate Immunity: more than a "guard" against invading pathogens.

9/14/2011 4th International Conference on Crossroads between Innate and Adaptive Immunity, Mykonos, Greece. A Keystone Biological System for Immune Surveillance and Homeostasis.

6/23/2011 5th International Complement Therapeutics Conference, Rhodes, Greece. An Update on Compstatin.

6/17/2011 8th International Innate Immunity Workshop, Crete, Greece. Innate Immunity: more than a "guard" against invading pathogens.

6/14/2011 9th International Conference on Pathways, Networks and Systems Medicine, Crete, Greece. Innate Immunity: more than a "guard" against invading pathogens.

4/8/2011 City University of Hong Kong. Innate Imnunity: more than a "guard" against invading pathogens.

3/4/2011 Systems Biology Institute, Seattle. Innate Immunity: more than a "guard" against invading pathogens.

1/19/2011 The University of Chicago, Committee on Microbiology Seminar Series. The Renessance of Complement.

12/2/2010 Department of Molecular Microbiology and Immunology, Brown University. The Renaissance of Complement.

10/2/2010 1st Biennial Symposium on AMD, Harvard Medical School, Boston. Complement Therapeutics.

9/16/2010 Somalogic, Boulder, Colorado. A "multidisciplinary" approach to understand disease and pathogenesis and develop therapeutics.

3/29/2010 3rd joJoint Conference of the German Society for Hygiene and Microbiology (DGHM) e.V. and the Association for General and Applied Microbiology (VAAM), Hanover, Germany. The Renaissance of Complement.

11/28/2009 1st International Conference on Molecular Cancer Research, Athens, Greece. Shifting the paradigm. Unexpected functions of Complement in Cancer.

11/27/2009 National Academy of Athens, Greece. Innate Immunity.

11/11/2009 University of Michigan, Department of Pathology. The Renaissance of Complement.

10/27/2008 Department of Pathology and Laboratory Medicine, University of Pennsylvania. System Biology Approaches to Disease Pathogenesis and Development of Therapeutics.

1/18/2008 Division of Allergy and Immunology, University of Pennsylvania. Complement Therapeutics.

10/26/2007 Durham, NC. 1st Annual DIRECT Dry AMD Meeting.  Complement Biology and Biochemistry.

10/19/2007 Department of Neurology Thomas Jefferson University. Systems approaches to disease pathogenesis and development of therapeutics.

9/25/2007 Department of Crystal and Structural Chemistry, Bijvoet Centre for Bimolecular Research, Utrecht University. The structures and functions of the Complement System.

6/24/2007 5th International Conferences on Pathways, Networks, and Systems: Theory and Experiments, Porto Heli, Greece. Systems approaches to disease pathogenesis and development of therapeutics.

6/13/2007 4th Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Porto Heli, Greece. Novel Complement Therapeutics.

6/5/2007 4th International Leukocyte Signal Transduction Workshop: Clinical implications of signaling pathways, Rhodos, Greece. Systems approaches to disease pathogenesis and development of therapeutics.

4/23/2007 2nd Biosciences Congress, University of Patras, Greece. Plenary lecture on "The Today’s challenges in biosciences".

4/19/2007 41st Annual Scientific Meeting of the European Society for Clinical Investigation, Uppsala,Sweden. Interference with complement activation.

2/6/2007 Stem Cell Biology Program, James Graham Brown Cancer Center University of Louisville. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.

12/7/2006 Division of Cell Biology and Biophysics, University of Missouri-Kansas City. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.

12/5/2006 GTCBio’s - Medicinal Chemistry at the 2nd Modern Drug Discovery & Development, Philadelphia, PA. Complement Inhibitors: From Bench to Bedside.

10/17/2006 4th International Conferences on Pathways, Networks, and Systems: Theory and Experiments, Mykonos, Greece. A "multidisciplinary" approach to understand disease pathogenesis and develop therapeutics.

6/30/2006 1st International Conference on Ovarian Cancer: State of the Art and Future Directions, Crete, Greece. From atoms to systems: "A "multidisciplinary" approach to understand disease pathogenesis and develop therapeutics.

6/7/2006 4th Innate Immunity Conference, Corfu, Greece. Protein-protein interactions in the complement system and development of complement therapeutics.

5/11/2006 University of Kalmar, Sweden. The today’s challenges in biosciences.

5/8/2006 Department of Clinical Immunology, University of Uppsala, Sweden. A "multidisciplinary" approach to today’s challagengs in biosciences.

3/15/2006 Department of Chemical Engineering and Materials Science, University of Minnesota. Rational Design of Complement Therapeutics.

10/11/2005 Grossroads between Innate and Adaptive Immunity, Rhodes, Greece. Intergrating innate immunity into a "systems context"; The complement paradigm.

10/4/2005 3rd International Conference on Pathways, Networks and Systems: Theory and Experiments, Rhodes, Greece. Integrating innate immunity into a "systems context"; The complement paradigm.

9/10/2005 13th Signal and Signal Processing in the Immune System. EFIS Conference, Balatonöszöd, HUNGARY. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.

6/7/2005 3rd Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Rhodes, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challagengs in biosciences.

5/31/2005 3rd Lymphocyte Signal Transduction Workshop, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challagengs in biosciences.

5/25/2005 2nd International Conference on Tissue Engineering, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.

5/20/2005 BIOMED Seminar, Engineering School Drexel University. From Atoms to Systems: A "multidisciplinary" approach to today’s challenges in biosciences.

5/12/2005 FOCIS, Boston, MA. A multidisciplinary approach to complement functions.

3/17/2005 Philadelphia's Science Center. From Atoms to Systems: A multidisciplinary approach to today's challenges in biosciences.

3/9/2005 Department of Immunology, Beijing Medical School, China. From Atoms to Systems: A multidisciplinary approach to today's challenges in biosciences.

1/31/2005 Computer Science Department, School of Computer Science, Carnegie Mellon. From Atoms to Systems: A multidisciplinary approach to today’s challenges in Biosciences.

12/21/2004 Department of Pathology, University of Michigan. A multidisciplinary approach to today’s challenges in biosciences.

12/15/2004 Department of Pathology, School of Dental Medicine, University of Pennsylvania. A "Cross-disciplinary" approach to Complement Mediated 9 Functions.

12/15/2004 Department of Pathology, School of Dental Medicine, University of Pennsylvania. A "Cross-disciplinary" approach to Complement Mediated Functions.

12/12/2004 Department of Pathology, Columbia University. Complement: more than a "guard" against invading pathogens.

9/10/2004 FEBS Immunology Summer Course, Killini, Greece. Complement: more than a "guard" against invading pathogens.

7/14/2004 Foundations of Computer Aided Process Design (FOCAPD) : Design through product and process design. De Novo Protein Design: An Interplay of Global Optimization, Mixed-Integer Optimization and Experiments.

5/3/2004 Department of Genetics, Case Western Reserve University, Cleveland, OH. A "multidisciplinary" approach to today’s challenges in biosciences.

4/28/2004 Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison. A "multidisciplinary' approach to Complement Mediated Functions.

4/22/2004 4th Orthopoxvirus Meeting, Washington DC. Vaccinia-Host Interactions.

3/2/2004 Enrique E. Ecker Memorial Lecture, Case Western Reserve University, Cleveland, OH. From Atoms to Systems: A "Cross-disciplinary" approach to Complement Mediated Functions.

1/22/2004 PENN center for Clinical Immunology, Seminars in Human Translational Immunology. Complement inhibitors: from bench to bedside.

12/8/2003 Department of Pathology, University of Pennsylvania. From Atoms to Systems: A "Metadisciplinary" approach to Innate Immunity.

12/4/2003 NIH/NIEHS Science Retreat on Comparative Systems Biology Approaches as Applied to Environmental Health. A Systems Biology Analysis of Innate Immunity.

11/28/2003 Departments of Biotechnology/Chemistry/Pharmacology, University of Modena, Italy. From Atoms to Systems: A "Metadisciplinary" approach to Innate Immunity.

11/24/2003 Division of Rheumatology, University of Pennsylvania. Systems Biology Analysis of Innate Immunity.

10/21/2003 SOL Sherry Thrombosis Research Center, Temple University. A Systems Biology Analysis of Innate Immunity.

9/30/2003 Aegean Conferences on Pathways, Networks, and Systems: Theory and Experiments, Santorini, Greece. A Systems Biology Analysis of Complement Functions.

9/16/2003 South Jersey ACS Meeting. Rational Design of Complement Inhibitors.

9/9/2003 Biochemical Society Focused Meeting, Stevenage, UK. Design of Inhibitors for Proteolytic Cascades. Rational Design of Complement Inhibitors.

8/3/2003 Baoding High Tech Developing Zone, China. Design of complement inhibitors.

6/10/2003 15th European Immunology Congress, Rhodes, Greece. Plenary Lecture on "Complement: more than a "guard" against invading pathogens.

2/17/2003 Department of Immunology, Beijing Medical School, China. Innate Immunity: More than a "Guard" against Invading Pathogens.

2/17/2003 University of Patras, Patras, Greece. Design of complement inhibitors.

2/12/2003 University of Ioannina, Ioannina, Greece. Post genomic era challenges.

12/10/2002 Microbiology and Immunology Distinguished Lecture Series, University of Texas Medical Branch, Galveston, TX. Innate Immunity: More than a "Guard" against Invading Pathogens.

11/13/2002 Exton, PA, 3-Dimentional Pharmaceuticals. Rational Design of Complement Inhibitors.

6/17/2002 67th Meeting of British Biochemical Society, Cardiff, UK. Rational Design of Complement Inhibitors.

3/27/2002 Department of Microbiology and Immunology, MCP-Drexel. Complement: More than a “guard” against invading pathogens.

10/11/2001 International Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Santorini Greece. Design of Complement Therapeutics 8.

10/10/2001 International Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Santorini Greece. The role of Complement in Developmental Processes.

10/1/2001 Perspectives in Tunicate Biology- IV Anton Dohrn Workshop, Ischia, Italy. The role of Complement in Developmental Processes.

6/22/2001 The 5th Nordic Symposium on Fish Immunology, Sundvollen, Norway. Structure and functions of trout complement proteins.

2/20/2001 Instituto Tecnologie Biomedichemie, CNR, Rome Italy. Therapeutic interventions in the complement system.

2/16/2001 Stazione Zoologica, Napoli, Italy. The diversity and evolution of innate immunity.

2/2/2001 Immunology Lecture series, Cornell University, Veterinary School, Ithaca, NY. Complement: New horizon.

1/12/2001 ICOS Corporation, Bothell, WA. Protein-protein interactions in the complement system and design of complement inhibitors.

12/6/2000 Pathology Lecture Series.University of Wisconsin-Madison. Protein-protein interactions in the complement system and design of complement inhibitors.

7/10/2000 St. George Hospital, Department of Immunology, Allergy & Infectious Diseases, University of New South Wales, Australia. Therapeutic potential of Compstatin.

10/25/1999 EU Advanced Workshop in Biotechnology- Genome Sequence and Comparative Analysis, Thessaloniki, Greece. High throughput protein analysis: Proteomics and Combinatorial Chemistry.

10/4/1999 Pharmacology Seminar, Dep. of Pharmacology, Univ. of Pennsylvania, PA. Therapeutic potential of Compstatin: A novel Complement Inhibitor Isolated from a phage library.

7/15/1999 FASEB Summer Research Conference on Phylogenetic Perspectives on the Vertebrate Immune System. Complement Phylogeny and Diversity.

4/1/1999 Millennium Biotherapeutics, Boston. Therapeutic potential of Compstatin.

11/11/1998 Marine Biotechnology Center, University of Maryland Special, Baltimore. Complement Diversity.

11/3/1998 Division of Hematology & Oncology, CHOP, Philadelphia, PA. Inhibition of complement and cellular activation in whole blood in extracorporeal circulation by Compstatin.

5/23/1998 Special Symposium on Biotechology – Athens Greece. The use of combinatorial libraries in the drug discovery process.

5/13/1998 University of Ioannina, Greece. The use of combinatorial libraries in the drug discovery process.

5/7/1998 24th Panhellenic Medical Congress, Athens-Greece. The future xenotransplant.

12/4/1997 University of Thessaloniki, Greece. Therapeutic potential of Compstatin; a novel complement inhibitor.

12/2/1997 University of Patras, Greece. Therapeutic potential of Compstatin; a novel” complement inhibitor.

11/12/1997 University of Oslo, Norway. Therapeutic potential of Compstatin; a novel complement inhibitor.

10/16/1997 IBC’s 3rd Annual Meeting, Washington D.C. Controlling the complement system. Complement inhibitor interfering with C3-ligand interactions.

5/2/1997 Institute of Molecular Medicine, UTC, Huston, TX. Complement and viral molecular mimicry.

10/18/1996 SangStat, Menlo Park, CA. A novel complement inhibitor isolated from a 7 phage-displayed random peptide library .

5/24/1996 Amgen Corporation, Boulder, Co. Protein-protein interactions in the complement system and viral molecular mimicry .

5/23/1996 University of Colorado, Department of Medicine, Denver, Co. Protein-protein interactions in the complement system and viral molecular mimicry.

10/26/1995 Children’s Hospital of Philadelphia, Division of Pulmonary Medicine. Molecular interactions in the complement system and viral molecular mimicry.

3/23/1995 Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Protein-protein interactions in the complement system and viral molecular mimicry .

3/21/1995 Institute Pasteur, Athens, Greece. Protein-protein interactions in the complement system and viral molecular mimicry.

3/20/1995 University of Patras, Department of Microbiology. Protein-protein interactions in the complement system and viral molecular mimicry.

12/7/1994 Umea University-Sweden, Medical School. Evasion strategies of microorganisms.

2/8/1994 University of Louisville, Department of Microbiology & Immunology. Structure, functioning and evolution of the third component of complement.

1/19/1994 Chiron Co., Emeryville, CA. Critical Care Seminar Series. Design of Complement inhibitors.

11/11/1993 Alexion Co., New Haven, CT. Protein-protein interactions in the complement system and design of complement inhibitors.

5/24/1993 AAI Meeting, Denver, Co. Phylogenetic analysis of C3.

3/9/1993 Temple University, Department of Microbiology & Immunology. Protein-protein interactions in the complement system.

2/3/1993 University of Pennsylvania, Research Center in Oral Medicine. Protein-protein interactions in the complement system.

12/3/1992 Umea University-Sweden, Medical School. Protein-protein interactions in the complement system.

10/24/1992 Fourth International Conference of Anticancer Research, Crete, Greece. Structure and functions of EBV/C3 receptors on human T lymphocytes.

6/5/1992 Washington University (Howard Hughes Scholar), Howard Hughes Medical Institute. Protein-protein interactions in the complement system.

5/16/1992 University of Patras, Department of Microbiology. Evasion Strategies of Microorganisms.

5/14/1992 Second World Conference of the Hellenic Bio-medical Diaspora, Athens, Greece. Structure, functions and phylogeny of C3.

5/11/1992 University of Pennsylvania, Division of Laboratory Medicine. Structure and functions of complement proteins.

8/28/1991 25 years of Biology in Patras, University of Patras, Department of Biology, Symposium. Structure, functions and phylogeny of the complement system.

3/6/1991 University of Pennsylvania, Department of Pediatrics, Division of Infectious Diseases and Immunology. Evasion Strategies of Microorganisms.

10/23/1990 University of Pennsylvania, Department of Obstetrics and Gynecology. Molecular aspects of the C3 interactions with other complement components and complement receptors.

10/9/1990 University of Pennsylvania, Immunology Colloquium. Molecular aspects of the C3 interactions with other complement components and complement receptors.

9/27/1990 University of Pennsylvania, Department of Chemistry. Protein-protein interactions in the complement system.

2/3/1990 Institute for Tropical Diseases, Hamburg, Germany. Protein-protein interactions.

12/14/1989 Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Protein-protein interactions.

12/7/1989 University of Heidelberg, Institute of Immunology, Heidelberg, FRG. The multifunctional role of the third component of complement.

2/2/1989 University of Lausanne, Department of Biochemistry, Lausanne, Switzerland. Structure and functions of the third component of complement.

1/20/1989 University of Pennsylvania, Department of Pathology and Laboratory Medicine. The complement system as a model system to study protein-protein interactions.

3/24/1988 University of Innsbruck, Institute for Hygiene, Innsbruck, Austria. The multifunctional role of the third component of complement.

2/16/1988 Autoimmune Disease Center, Scripps Clinic and Research Foundation, La Jolla. Molecular aspects of the C3 interactions with complement receptors and other complement components.

2/11/1988 Molecular Biology Institute, SDSU, San Diego. Molecular aspects of the C3 interactions with complement receptors and other complement components.

2/2/1988 Institute Pasteur, Athens, Greece. The complement system as a model to study protein-protein interactions.

6/11/1987 Peptide synthesis Seminar ABI, Basel. Synthetic Peptides: A tool to study protein-protein interactions.

6/5/1987 Institute of Molecular Biology, University of Madrid, Spain. The complement system: A model to study protein-protein interactions.

5/15/1987 International Titisee Conferences on: "Proteolytic processing and biological functions. Proteolytic processing of human C3 and its interactions with complement receptors.

4/28/1987 Institute Pasteur, Athens, Greece. The complement system.

1/29/1987 Institute of Clinical Immunology, Inselspital, University of Bern. The complement system.

12/17/1986 Department of Biology, Roche, Basel. Molecular interactions in the complement system.

9/19/1986 FEBS Summer School (Advanced course) on Immunological Methods and Applications, Göd, Hungary. Molecular interactions in the complement system.

5/30/1986 University of Texas at Houston, M. D. Anderson Hospital, Dept. of Immunology. The multifunctional role of the third component of complement.

12/9/1985 Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Molecular aspects of the C3 interaction with other complement components and complement receptors.

9/16/1985 Basel Institute for Immunology, Basel, Switzerland. Molecular aspects of the C3 interaction with other complement components and complement receptors.

8/27/1985 National Institutes of Health/Kidney Disease Section Seminar. Molecular aspects of the C3 interaction with other complement components and complement receptors.

4/9/1985 Immunology and Gesellschaft für Immunologie, Lake Balaton, Hungary. 4th Balaton Meeting on "Signals and signal processing in the immune system" Organized by The Hungarian Society for "Molecular aspects of the C3 interaction with CR2, CR3, Factor H and bovine conglutinin".

1/25/1985 Aristotelian University of Thessaloniki, Greece, Department of Biology. The use of monoclonal antibodies in Biomedical Sciences.

1/24/1985 Aristotelian University of Thessaloniki, Greece, Department of Biology. The complement system.

10/29/1984 Special workshop on complement receptors, Coconut Grove, Florida. Molecular aspects of the C3 interaction with complement receptors.

2/24/1984 University of Ioannina, Greece, Department of Medicine. Interaction of C35 fragments with complement receptors and regulatory proteins.

2/22/1984 University of Innsbruck, Institute for Hygiene, Innsbruck, Austria. Mapping of the properdin C5 and C3dR binding sites on the third component of complement.

2/21/1984 University of Heidelberg, Institute of Immunology, Heidelberg, FRG. Interaction of C3 fragments with complement receptors and regulatory proteins.

2/20/1984 Johannes-Gutenberg University Institute for Medical Microbiology, Mainz, FRG. Interaction of C3 fragments with complement receptors.

9/15/1981 Duke University Medical Center, Department of Medicine and Pathology. Complement Receptors.

7/13/1981 University of Lausanne, Department of Biochemistry, Lausanne, Switzerland. Isolation and characterization of three different complement receptors.